Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Monenschein

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry|December 3, 2014
Synthesis and preliminary biological evaluation of potent and selective 2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitors with improved solubilityRobert M Rzasa, Michael J Frohn, Kristin L Andrews, et al.
Journal of Medicinal Chemistry|August 28, 2018
Discovery of TRPM8 Antagonist ( S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of MigraineDaniel B Horne, Kaustav Biswas, James Brown, et al.
Science Signaling|December 3, 2024
Structural insights into the high basal activity and inverse agonism of the orphan receptor GPR6 implicated in Parkinson's diseaseMahta Barekatain, Linda C Johansson, Jordy H Lam, et al.
Nature Communications|January 13, 2026
Identification of a thermogenic target in the dorsal raphe nucleus for weight management in miceAlexandre Moura-Assis, Kaja Plucińska, David Meseguer, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of β-SecretaseMatthew R Kaller, Scott S Harried, Brian Albrecht, et al.
Journal of Medicinal Chemistry|April 4, 2012
Design and preparation of a potent series of hydroxyethylamine containing β-secretase inhibitors that demonstrate robust reduction of central β-amyloidMatthew M Weiss, Toni Williamson, Safura Babu-Khan, et al.
Journal of Medicinal Chemistry|April 4, 2012
Design and synthesis of potent, orally efficacious hydroxyethylamine derived β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitorsThomas A Dineen, Matthew M Weiss, Toni Williamson, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry|December 3, 2014
Synthesis and preliminary biological evaluation of potent and selective 2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitors with improved solubilityRobert M Rzasa, Michael J Frohn, Kristin L Andrews, et al.
Journal of Medicinal Chemistry|August 28, 2018
Discovery of TRPM8 Antagonist ( S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of MigraineDaniel B Horne, Kaustav Biswas, James Brown, et al.
Science Signaling|December 3, 2024
Structural insights into the high basal activity and inverse agonism of the orphan receptor GPR6 implicated in Parkinson's diseaseMahta Barekatain, Linda C Johansson, Jordy H Lam, et al.
Nature Communications|January 13, 2026
Identification of a thermogenic target in the dorsal raphe nucleus for weight management in miceAlexandre Moura-Assis, Kaja Plucińska, David Meseguer, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of β-SecretaseMatthew R Kaller, Scott S Harried, Brian Albrecht, et al.
Journal of Medicinal Chemistry|April 4, 2012
Design and preparation of a potent series of hydroxyethylamine containing β-secretase inhibitors that demonstrate robust reduction of central β-amyloidMatthew M Weiss, Toni Williamson, Safura Babu-Khan, et al.
Journal of Medicinal Chemistry|April 4, 2012
Design and synthesis of potent, orally efficacious hydroxyethylamine derived β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitorsThomas A Dineen, Matthew M Weiss, Toni Williamson, et al.
Pageof 2